(Q57665261)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

title

Lung cancer mortality risk among breast cancer patients treated with anti-estrogens (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

0 references

1 reference

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Vincent Vinh-Hung

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

10

Elisabetta Rapiti

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1

Christine Bouchardy

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

9

Georges Vlastos

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Robin Schaffar

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Gerald Fioretta

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Hyma Schubert

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Jean-Charles Soria

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Helena M Verkooijen

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

language of work or name

English

0 references

publication date

24 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

volume

117

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

1288-1295

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

Gender difference in the activity but not expression of estrogen receptors alpha and beta in human lung adenocarcinoma cells

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Activity and intracellular location of estrogen receptors alpha and beta in human bronchial epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Non-small-cell lung cancer and breast carcinoma: chemotherapy and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Intratumoral estrogens and estrogen receptors in human non-small cell lung carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Combined targeting of the estrogen receptor and the epidermal growth factor receptor in non-small cell lung cancer shows enhanced antiproliferative effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Hormone replacement therapy and lung cancer risk: a case-control analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Hormone replacement therapy and lung cancer risk in Chinese.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Hormone replacement therapy is associated with decreased survival in women with lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Reduced mortality associated with long-term postmenopausal estrogen therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Hormone replacement therapy and survival in lung cancer in postmenopausal women in a rural population

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Immunohistochemical expression of estrogen and progesterone receptors identifies a subset of NSCLCs and correlates with EGFR mutation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Aromatase inhibitors in human lung cancer therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Aromatase expression predicts survival in women with early-stage non small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Tobacco and estrogen metabolic polymorphisms and risk of non-small cell lung cancer in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

7 January 2021

Risk of cancer in women receiving hormone replacement therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

7 January 2021

Re: Endocrine factors and adenocarcinoma of the lung in women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

7 January 2021

Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.25638

7 January 2021

Identifiers

DOI

10.1002/CNCR.25638

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21264820%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

1 reference